TREATMENT OF THE INSULIN RESISTANCE SYNDROME WITH SELECTIVE CGMP PDE5 INHIBITORS - Patent 1307183

(19)

(11)

EP 1 307 183 A2

(12)

(88)	Date of publication A3:
	23.01.2003

(43)	Date of publication:
	07.05.2003 Bulletin 2003/19

(21)	Application number: 01954266.1

(22)	Date of filing: 06.08.2001

(51)	International Patent Classification (IPC)⁷: A61K 31/00, A61K 31/505, A61K 31/5355, A61K 31/535, A61K 31/4985, A61K 31/495, A61K 31/53, A61K 38/28, A61K 45/06, A61P 3/04, A61P 3/06, A61P 3/08, A61P 3/10, A61P 9/12, A61P 9/10, A61P 7/04

(86)	International application number:
	PCT/IB0101/428

(87)	International publication number:
	WO 0201/3798 (21.02.2002 Gazette 2002/08)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

11.08.2000 US 224928 P
15.12.2000 GB 0030649
02.02.2001 US 266083 P
15.03.2001 GB 0106465
15.03.2001 GB 0106468
13.07.2001 GB 0117134

(71)	Applicants:
	Pfizer Limited Sandwich,Kent CT13 9NJ (GB) GB PFIZER INC. New York, N.Y. 10017 (US) AT BE CH CY DE DK ES FI FR GR IE IT LU MC NL PT SE TR

(72)	Inventors:
	FRYBURG, David Albert Groton, CT 06340 (US) GIBBS, Earl Michael Groton, CT 06340 (US) KOPPIKER, Nandan Parmanand Groton, CT 06340 (GB)

(74)	Representative: Motion, Keith Robert et al
	Pfizer LimitedPatents DepartmentRamsgate Road Sandwich,Kent CT13 9NJ Sandwich,Kent CT13 9NJ (GB)

(54)	TREATMENT OF THE INSULIN RESISTANCE SYNDROME WITH SELECTIVE CGMP PDE5 INHIBITORS